Press Releases


Jan. 25, 2021

A 50-year legacy of innovation and a continued commitment to Science. Results. Trust.

MARLBOROUGH, MASS.,  Jan. 25, 2021 Candela, a leading global medical aesthetic device company, today announced the availability of the Frax Pro™ system. The FDA-cleared, non-ablative fractional …

Read More
Jan. 14, 2021

Merz Aesthetics and Candela Corporation launch commercial collaboration creating broad medical aesthetics portfolio.

Committed to innovative customer solutions and meeting patient demand for full-spectrum of medical aesthetic treatment.

RALEIGH, N.C. – January 14, 2021 – In a unique commercial collaboration, …

Read More
June 17, 2020

The CO2RE laser platform offers women a nonsurgical, hormone-free treatment for genitourinary syndrome of menopause and stress urinary incontinence

MARLBOROUGH, MASSACHUSETTS, JUNE 17, 2020 – Candela Corporation, a leading global aesthetic device company, today announced that Health Canada …

Read More
Jan. 31, 2020

Candela to become the exclusive global commercial partner for the Exceed™ medical microneedling system of MT.DERM

MARLBOROUGH, Mass. and BERLIN, Jan. 31, 2020 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, has entered into an exclusive collaboration …

Read More
July 16, 2019

Wayland, Mass. and Yokneam, Israel, July 16, 2019 -- Candela Corporation, a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital, Lumenis Ltd., a global leader in the field …

Read More
May 5, 2019

30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the E.V.A. clinic’s-Vascular Birthmarks Foundation’s International Congress on Vascular Anomalies in Athens, Greece, June 7-8, 2019.

For the second year the Vascular Birthmark Foundation (VBF) organizes …

Read More
March 20, 2019

WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd. and Candela Corporation (collectively, "Candela"), a leading global aesthetic device company and the exclusive licensee of certain patents of General Hospital Corporation, d/b/a Massachusetts General Hospital …

Read More
March 14, 2019

JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs. surgery) for birthmarks, port wine stains and other vascular related skin conditions on the face and body using the Vbeam laser system.

WAYLAND, …

Read More
March 1, 2019

New brand reflects commitment to Science, Results, Trust

WAYLAND, MASSACHUSETTS, March 1, 2019 – Syneron-Candela, a leading global medical aesthetic device company, announced today that it has rebranded the company to Candela and will be unveiling new corporate branding at …

Read More
Nov. 12, 2018

WAYLAND, MASSACHUSETTS, NOVEMBER 12, 2018 – Candela Corporation, a leading global aesthetic device company, announces that the Profound® treatment has been named “New Treatment of the Year” by The Global Aesthetic Awards, a leading aesthetic industry award, also known …

Read More
Oct. 1, 2018

Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets

WAYLAND, MASSACHUSETTS, October 1, 2018 - Syneron Candela announces the opening of Syneron Candela Korea Co Ltd, a new headquarters designed to support all commercial activities for …

Read More
Sept. 28, 2018

Over 30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the Vascular Birthmarks Foundation's 18th Annual Conference.

WAYLAND, Mass., Sept. 26, 2018 /PRNewswire/ -- Candela Corporation, a leading global manufacturer of energy-based devices, announces it …

Read More
Sept. 5, 2018

Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices

WAYLAND, MASSACHUSETTS, September 5, 2018 – Candela Corporation, a leading global aesthetic device company, announces the acquisition of …

Read More
July 17, 2018

The new Vbeam Prima takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) platform to the next level.

WAYLAND, MASSACHUSETTS, JULY 17, 2018 – Candela Corporation, a leading global aesthetic device company, announces the U.S. Food and Drug Administration …

Read More

Back to top

We use cookies on this site to enhance your user experience.

By continuing to browse you are agreeing to our use of cookies